Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress

Dandan Tang,Qing Zhang,Huxinyue Duan,Xun Ye,Jia Liu,Wei Peng,Chunjie Wu
DOI: https://doi.org/10.1155/2022/9218738
2022-02-10
Oxidative Medicine and Cellular Longevity
Abstract:Polydatin, one of the natural active small molecules, was commonly applied in protecting and treating liver disorders in preclinical studies. Oxidative stress plays vital roles in liver injury caused by various factors, such as alcohol, viral infections, dietary components, drugs, and other chemical reagents. It is reported that oxidative stress might be one of the main reasons in the progressive development of alcohol liver diseases (ALDs), nonalcoholic liver diseases (NAFLDs), liver injury, fibrosis, hepatic failure (HF), and hepatocellular carcinoma (HCC). In this paper, we comprehensively summarized the pharmacological effects and potential molecular mechanisms of polydatin for protecting and treating liver disorders via regulation of oxidative stress. According to the previous studies, polydatin is a versatile natural compound and exerts significantly protective and curative effects on oxidative stress-associated liver diseases via various molecular mechanisms, including amelioration of liver function and insulin resistance, inhibition of proinflammatory cytokines, lipid accumulation, endoplasmic reticulum stress and autophagy, regulation of PI3K/Akt/mTOR, and activation of hepatic stellate cells (HSCs), as well as increase of antioxidant enzymes (such as catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH), superoxide dismutase (SOD), glutathione reductase (GR), and heme oxygenase-1 (HO-1)). In addition, polydatin acts as a free radical scavenger against reactive oxygen species (ROS) by its phenolic and ethylenic bond structure. However, further clinical investigations are still needed to explore the comprehensive molecular mechanisms and confirm the clinical treatment effect of polydatin in liver diseases related to regulation of oxidative stress.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the pharmacological effects of polydatin, as a natural active small molecule, in protecting and treating liver diseases and its potential molecular mechanisms, especially achieving its protective effects by regulating oxidative stress. The paper emphasizes the crucial role of oxidative stress in the development of various liver diseases, such as alcoholic liver disease (ALD), non - alcoholic fatty liver disease (NAFLD), liver injury, liver fibrosis, liver failure (HF) and hepatocellular carcinoma (HCC). The author reviews how polydatin counteracts oxidative stress through multiple molecular mechanisms, thereby producing protective and therapeutic effects on the above - mentioned liver diseases. These mechanisms include improving liver function and insulin resistance, inhibiting pro - inflammatory cytokines, lipid accumulation, endoplasmic reticulum stress and autophagy, regulating the PI3K/Akt/mTOR signaling pathway and activating hepatic stellate cells (HSCs), while increasing the levels of antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH), superoxide dismutase (SOD), glutathione reductase (GR) and heme oxygenase - 1 (HO - 1). In addition, polydatin can also counteract reactive oxygen species (ROS) through its phenolic and vinyl structures and play the role of a free - radical scavenger. However, the author also points out that further clinical studies are still needed to explore the comprehensive molecular mechanisms and clinical efficacy of polydatin in the treatment of liver diseases related to oxidative stress regulation.